1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 31-40 of 56 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2010A novel polymorphism in a forkhead box A1 (FOXA1) binding site of the human UDP glucuronosyltransferase 2B17 gene modulates promoter activity and is associated with altered levels of circulating androstane-3α,17β-diol glucuronideHu, D.; Gardner-Stephen, D.; Severi, G.; Gregory, P.; Treloar, J.; Giles, G.; English, D.; Hopper, J.; Tilley, W.; MacKenzie, P.
2013Research resource: Nuclear receptors as transcriptome: Discriminant and prognostic value in breast cancerMuscat, G.; Eriksson, N.; Byth, K.; Loi, S.; Graham, D.; Jindal, S.; Davis, M.; Clyne, C.; Funder, J.; Simpson, E.; Ragan, M.; Kuczek, E.; Fuller, P.; Tilley, W.; Leedman, P.; Clarke, C.
2012Minireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?Hickey, T.; Robinson, J.; Carroll, J.; Tilley, W.
2008The Contribution of Different Androgen Receptor Domains to Receptor Dimerization and SignalingCentenera, M.; Harris, J.; Tilley, W.; Butler, L.
2007Identification of novel androgen receptor target genes in prostate cancerJariwala, U.; Prescott, J.; Jia, L.; Barski, A.; Pregizer, S.; Cogan, J.; Arasheben, A.; Tilley, W.; Scher, H.; Gerald, W.; Buchanan, G.; Coetzee, G.; Frenkel, B.
2004Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancerSuwiwat, S.; Ricciardelli, C.; Tammi, R.; Tammi, M.; Auvinen, P.; Kosma, V.; LeBaron, R.; Raymond, W.; Tilley, W.; Horsfall, D.
2009Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancerPeters, A.; Buchanan, G.; Ricciardelli, C.; Bianco-Miotto, T.; Centenera, M.; Harris, J.; Jindal, S.; Segara, D.; Jia, L.; Moore, N.; Henshall, S.; Birrell, S.; Coetzee, G.; Sutherland, R.; Butler, L.; Tilley, W.
2006Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancerSeveri, G.; Morris, H.; MacInnis, R.; English, D.; Tilley, W.; Hopper, J.; Boyle, P.; Giles, G.
2012Dual roles of PARP-1 promote cancer growth and progressionSchiewer, M.; Goodwin, J.; Han, S.; Brenner, J.; Augello, M.; Dean, J.; Liu, F.; Planck, J.; Ravindranathan, P.; Chinnaiyan, A.; McCue, P.; Gomella, L.; Raj, G.; Dicker, A.; Brody, J.; Pascal, J.; Centenera, M.; Butler, L.; Tilley, W.; Feng, F.; et al.
2007Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine-rich tetratricopeptide repeat containing protein αBuchanan, G.; Ricciardelli, C.; Harris, J.; Prescott, J.; Yu, Z.; Jia, L.; Butler, L.; Marshall, V.; Scher, H.; Gerald, W.; Coetzee, G.; Tilley, W.

Discover